Somatostatinoma of the Pancreas; Difficulties in Preoperative Diagnostic Approaches - A Case Report

• Authors: Daria Dranka-Bojarowska , Marek Olakowski , Paweł Lampe
• Languages of publication: EN

Abstracts

EN

Somatostatinoma is the rarest neuroendocrine tumor of the digestive tract. About 60% of somatostatinomas arise in the pancreas. This study presents a case of a 51-year-old male patient with tumor of the pancreas. Despite wide preoperative diagnostic examinations, it was impossible to determine the histological type of the tumor preoperatively. The patient was qualified for surgical procedure, during which the tumor was enucleated. The tumor was classified as somatostatinoma through immunohistochemical examination. The postoperative course was complicated by a small fluid collection, which arose in area of enucleation; the cistern was absorbed spontaneously. Currently, the patient is under surgical ambulatory care and is in general, in good condition.

Keywords

EN

somatostatinoma; pancreatic neuroendocrine neoplasms; gastroenteropancreatic neuroendocrine tumors - GEP-NET

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2007
• Volume: 79
• Issue: 2
• Pages: 129-133

Dates

published

1 - 2 - 2007

online

24 - 9 - 2007

Contributors

author

Daria Dranka-Bojarowska

• Department of Digestive Tract Surgery, Silesian Medical University, Katowice

author

Marek Olakowski

• Department of Digestive Tract Surgery, Silesian Medical University, Katowice

author

Paweł Lampe

• Department of Digestive Tract Surgery, Silesian Medical University, Katowice

References

• Harris GJ, Tio F, Cruz AB Jr: Somatostatinoma: a case report and review of the literature. J Surg Oncol 1987; 36: 8-16.[Crossref]
• Bolanowski M, Kos-Kudła B: Etiologia, występowanie, podział kliniczny i objawy guzów GEP. Onkologia po Dyplomie. Wydanie specjalne. 2005; 7-10.
• Azimuddin K, Chamberlain RS: The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001; 81: 511-25.[Crossref][PubMed][WoS]
• House MG, Yeo CJ, Schulick RD: Periampullary pancreatic somatostatinoma. Ann Surg Oncol 2002; 9: 869-74.[Crossref][PubMed]
• Vinik AL, Strodel WE, Eckhauser FE et al.: Somatostatinomas, Pomas, neurotensinomas. Semin Oncol 1987; 14: 263-81.
• Franek E: Hormonalnie czynne neuroendokrynne guzy trzustki. Przegl Gastroenterol 2006; 1: 22-28.
• Soga J, Yakuwa Y: Somatostatinoma inhibitory syndrome:a statistical evaluation of 173 reported cases as compared to other pancreatic endocrino-mas. J Exp Clin Cancer Res 1999; 18: 13-22.
• Mullan MH, Gauger PG, Thompson NW: Endocrine tumors of the pancreas: review and recent advances. ANZ J Surg 2001; 71: 475-82.[PubMed][Crossref]
• Kaltsas GA, Besser GM, Grossman AB: Diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25: 458-511.[Crossref][PubMed]
• Anderson MA, Carpenter S, Thompson NW et al.: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of pancreas. Am J Gastroenterol 2000; 95: 2271-77.[Crossref]
• Tjon A, Tham RT, Jansen JB et al.: Imaging features of somatostatinoma: MR, CT, US and angiography. J Comput Assist Tomogr 1994; 18: 427-31.
• Semelka RC, Custodio CM, Cem Balci M et al.: Neuroendocrine tumors of pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000; 11: 141-48.[Crossref]
• Marakis G, Ballas K, Rafailidis S et al.: Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis - a case report. Pancreatology 2005; 5: 295-99.[Crossref]
• Becherer A, Szabo M, Karanikas G et al.: Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 2004; 45: 1161-67.
• Norton JA, Cromack DT, Shawker TH: Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 1988; 207: 160-68.[PubMed][Crossref]
• Ramage JK, Davies AHG, Ardill J et al.: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54: 1-16.[WoS]
• Plöckinger U, Wiedenmann B: Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours. Neuroendocrinology 2004; 80: 35-38.[Crossref][PubMed]
• Brentjens R, Saltz L: Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001; 81: 527-542.[Crossref]
• Cichocki A: Chirurgiczne leczenie guzów neuroendokrynnych przewodu pokarmowego. Onkologia po Dyplomie. Wydanie specjalne. 2005; 42-46.
• Madeira I, Terris B, Voss M et al.: Prognostic factor in patients with endocrine tumors of the duodenopancreatic area. Gut 1998; 43: 422-27.[Crossref]

Identifiers

DOI

10.2478/v10035-007-0021-y